Inflammation and cancer: advances and new agents

Shanthini M. Crusz,Frances R. Balkwill
DOI: https://doi.org/10.1038/nrclinonc.2015.105
IF: 78.8
2015-06-30
Nature Reviews Clinical Oncology
Abstract:Key PointsInflammation and innate immunity have a vital and complex role in driving tumorigenesisStrong epidemiological and preclinical data support an anti-inflammatory approach to prevention and treatment of cancerSeveral therapeutic agents targeting inflammatory cytokines, transcription factors and immune cells are being developed and tested in the clinical settingCurrent successes of treatments targeting adaptive immunity indicate a great need to further our clinical understanding of the inflammatory and innate immune system to identify further targets for cancer treatmentCombining treatments that target the adaptive and innate immune systems in the tumour microenvironment might be advantageous
oncology
What problem does this paper attempt to address?